Copyright: ©Author(s) 2026.
World J Orthop. May 18, 2026; 17(5): 116844
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.116844
Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.116844
Table 7 Comparison of adverse reactions and remedial indicators between the two patient groups, median (25th-75th percentiles), n (%)
| Group | Remedial indicator | Adverse reactions | |||
| Sufentanil dose | Number of compressions | PONV | Shivering | Excessive sleepiness | |
| Control (n = 40) | 81.0 (70.0-91.0) | 11.0 (8.0-16.0) | 15 (37.5) | 7 (17.5) | 16 (40.0) |
| LB (n = 40) | 68.0 (66.0-78.0)a | 8.0 (5.0-9.0)a | 6 (15.0) | 3 (7.5) | 3 (7.5) |
| z/χ2 value | -2.855 | -3.393 | 5.230 | 1.829 | 11.665 |
| P value | 0.004 | 0.001 | 0.041 | 0.311 | 0.001 |
- Citation: Liu H, Jia T, Shuai SC, Zhao JB. Effect of liposomal bupivacaine for iliac fascia block on postoperative cognitive dysfunction in patients with femoral neck fractures. World J Orthop 2026; 17(5): 116844
- URL: https://www.wjgnet.com/2218-5836/full/v17/i5/116844.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i5.116844